Cited by 32Gut microbiota and healthInfant Nutrition and HealthAntibiotic Resistance in Bacteria

Breastfeeding and early Bifidobacterium-driven microbial colonization shape the infant gut resistome

Open access
Samarra, Anna, Alcañiz, Alejandro J., Martínez-Costa, Cecilia, Marina, Alberto, Comas, Iñaki, Segata, Nicola, Quijada, Narciso M., Collado, Maria Carmen·2025·Nature Communications

Abstract

The assembly of the gut resistome in early life is key to infant health. Specific perinatal factors such as cesarean section (C-section), antibiotic exposure and lack of breastfeeding practices are detrimental to proper microbial development and increase the antimicrobial resistance genes (ARGs). Using 265 gut longitudinal metagenomes from 66 mother-infant pairs, we investigated how perinatal factors influence the acquisition and dynamics of ARGs during the first year of life. Our findings reveal that Bifidobacterium plays a crucial role in modulating the infant resistome, with its high relative abundance being associated with a lower ARG load. Exclusive breastfeeding during the first month of life accelerates the reduction of ARGs and ensures a lower resistome burden at six months. Moreover, early breastfeeding cessation correlates with a higher ARG load, underscoring its long-term influence on microbial resilience. Importantly, we identify exclusive breastfeeding as a key strategy to mitigate the impact of C-section delivery on the infant gut resistome, counteracting the early-life antibiotic exposure associated with this procedure and the resulting resistance acquisition. By promoting a microbiome enriched in Bifidobacterium, breastfeeding may help suppress ARG-carrying taxa, reducing the risk of resistance dissemination. Our findings underscore the importance of breastfeeding as a natural intervention to shape the infant microbiome and resistome. Supporting breastfeeding through public health policies could help limit the spread of antimicrobial resistance in early life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-025-61154-w

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bifidobacterium supplementation has been associated with lower ARG abundance in the infant gut microbiome, likely due to the competitive exclusion of ARG-rich pathobionts.

    “Bifidobacterium, and Bifidobacterium supplementation has been associated with lower ARG abundance in the infant gut microbiome, likely due to the competitive exclusion of ARG-rich pathobionts56–59.”

    From Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. (2025) · cites this paper as [59]

    The Results section reports significantly lower ARG loads in infants with high Bifidobacterium abundance, and the Discussion suggests Bifidobacterium may suppress AMR-carrying taxa. The paper does not establish that Bifidobacterium supplementation lowers ARG abundance or demonstrate competitive exclusion as the mechanism. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [36]Gueimonde, M. & Arboleya, S. in Bifidobacteria: Methods and Protocols. (Springer US, New York, NY, 2021).
  2. [46]WHO Recommendation on Prophylactic Antibiotics for Women Undergoing Caesarean Section. (World Health Organization, Geneva, 2021). 34185445
  3. [73]Carattoli, A. & Hasman, H. In Horizontal Gene Transfer: Methods and Protocols (Springer US, New York, NY, 2020).
  4. [74]Wickham, H. Ggplot2. (Springer International Publishing, Cham, 2016).

Cited by

Sorted by citations

Authors
Samarra, A., Alcañiz, A. J., Martínez-Costa, C., Marina, A., Comas, I., Segata, N., Quijada, N. M., & Collado, M. C.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • University of Trento (IT)
  • Universidad de Salamanca (ES)
Corresponding author
Quijada, Narciso M.
Venue
Nature Communications
Published
2025-07-02
Volume
16
Issue
1
Pages
6099-6099
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4411947467
Cited by
32
References
74
Citations by year
2026: 27 · 2025: 5
FWCI
9.62
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Iris (University of Trento) (submittedVersion, cc-by-nc-nd)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
Funders
  • American Concrete Institute Foundation
  • European Commission (MAMI-639226 project, 639226, 13039/501100011033, 501100011033, H2020, 101094099)
  • Generalitat Valenciana (501100011033, PROMETEO2020/12, CIPROM2023/030, ACIF/2021)
  • Ministerio de Ciencia e Innovación (MCIN/AEI/10, .13039/501100011033, CEX 2021-001189-S, / AEI/10, PID2022-139475OB-I00, 501100011033, PID2022)
  • Horizon 2020 Framework Programme
  • HORIZON EUROPE Framework Programme (101094099)
  • Agencia Estatal de Investigación (501100011033, 13039, .13039/501100011033, CEX2021-001189 -S, H2020, AEI/10)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
Keywords
breastfeeding, Bifidobacterium, infant gut microbiota, antimicrobial resistance genes, resistome, cesarean section, antibiotic exposure, exclusive breastfeeding, breastfeeding cessation, perinatal factors, mother-infant dyads, early-life microbial colonization
MeSH terms
Gastrointestinal Microbiome, Adult, Anti-Bacterial Agents, Bifidobacterium, Breast Feeding, Cesarean Section, Feces, Female, Humans, Infant, Infant, Newborn, Male, Milk, Human, Drug Resistance, Bacterial, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review